Ignite Creation Date:
2024-05-06 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05205200
Status:
RECRUITING
Last Update Posted:
2024-02-08
First Post:
2022-01-11
Brief Title:
Immune Therapy in HR-positiveHER2-negative Metastatic Breast CancerENIGMA-BCTOP-L-M02
Sponsor:
Fudan University
Organization:
Fudan University
Organization Data
Organization:
Fudan University
Class:
OTHER
Study ID:
FUSCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fudan University
Lead Sponsor Class:
OTHER
Responsible Party:
Zhimin Shao
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fudan University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Affiliated Hospital of Nantong University | OTHER |
| Peking University Cancer Hospital Institute | OTHER |
| First Hospital of China Medical University | OTHER |
| Sun Yat-sen University | OTHER |
| First Affiliated Hospital Xian Jiaotong University | OTHER |
| Liaoning Tumor Hospital Institute | OTHER |
| Chongqing University Cancer Hospital | OTHER |
| Northern Jiangsu Peoples Hospital | OTHER |
| Fujian Medical University Union Hospital | OTHER |
| Ningbo Medical Center Lihuili Hospital | OTHER_GOV |
| Shanghai First Maternity and Infant Hospital | OTHER |
| Shanghai 6th Peoples Hospital | OTHER |